The Prescription Pain Medication Market Analysis 2025 – Insights for Long-Term Investment & Planning

June 19, 2025 06:56 PM AEST | By EIN Presswire
 The Prescription Pain Medication Market Analysis 2025 – Insights for Long-Term Investment & Planning
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, June 19, 2025 /EINPresswire.com/ -- What Is The Growth Trajectory Of The Prescription Pain Medication Market?
As per the comprehensive analysis in the report, the prescription pain medication market size has grown considerably in recent years. It is projected to grow from $73.59 billion in 2024 to $77.97 billion in 2025, reflecting the sharp rise in the prevalence of chronic pain, an increasing number of surgical procedures, a heightened focus on palliative care, and a marked surge in the incidence of musculoskeletal disorders.

How Fast Will The Prescription Pain Medication Market Grow In The Coming Years?
Looking further ahead, the prescription pain medication market size is poised for an even stronger growth trajectory in the coming years. It is set to balloon to $97.23 billion in 2029, maintaining a 5.7% CAGR throughout the forecast period. Driving this steep growth is a combination of factors such as an amplified demand for personalized medicine, renewed focus on post-traumatic pain management, increasing adoption of telemedicine for pain management, growing patient inclination towards opioid alternatives, and a heightened prevalence of neuropathic pain. Couple this with major industry trends, such as the development of non-opioid pain alternatives and digital health integration as well as disruptive innovation in targeted pain therapies, combination pain medications and non-addictive pain medications, and the future looks promising for the prescription pain medication market.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=24385&type=smp

What Is Driving The Prescription Pain Medication Market Growth?
One major and ubiquitous growth driver identified is the increasing prevalence of arthritis, which is expected to significantly fuel the growth of the prescription pain medication market. Characterized by inflammation of one or more joints that causes pain, swelling, stiffness, and reduced range of motion, arthritis is becoming increasingly common due to obesity. The excess body weight particularly puts stress on joints, especially the knees, promoting inflammation and further complicating the disorder. That's where prescription pain medication comes into play, helping manage arthritis by alleviating inflammation and pain, enabling enhanced joint function, and significantly improving the overall quality of life for the patients.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/prescription-pain-medication-global-market-report

Who Are The Key Players Operating In The Prescription Pain Medication Market?
Among the major companies dominating the Prescription pain medication market are Mallinckrodt Public Limited Company, Pfizer Inc., Johnson And Johnson, Merck And Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, GlaxoSmithKline Public Limited Company, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Mylan N.V., Sandoz, Inc, Bausch Health Companies Inc., Purdue Pharma L.P., and Endo International Plc

What Major Trends Are Fueling The Growth Of The Prescription Pain Medication Market?
These industry leaders are now focusing on innovatively developing alternative therapies, particularly non-opioid painkillers, to address the escalating concerns over opioid addiction and enhance patient safety.

How Is The Prescription Pain Medication Market Segmented?
Giving a snapshot of market segments, the report reveals that the prescription pain medication market is segmented by type, route of administration, application, and distribution channel. Each of these primary segments are further detailed into respective sub-segments for a comprehensive understanding of the market.

How Is The Prescription Pain Medication Market Spread Globally?
What's interesting about the regional market insights is that while North America was the largest region in the prescription pain medication market in 2024, Asia-Pacific is tipped to be the fastest-growing region in the forecast period.

Browse Through More Similar Reports By The Business Research Company:
Omega 3 Prescription Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/omega-3-prescription-drugs-global-market-report

Pain Patch Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pain-patch-global-market-report

Topical Pain Relief Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/topical-pain-relief-global-market-report

About The Business Research Company
Learn More About The Business Research Company. With over 15000+ reports spanning 27 industries and 60+ geographies, The Business Research Company is reputed for offering comprehensive, data-rich research and insights. Fuelled by 1,500,000 datasets, complimented by robust in-depth secondary research, and tinged with unique insights from industry leaders, you can receive the information you need to stay ahead of the curve.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.